У нас вы можете посмотреть бесплатно Generative AI Agents in Medical Affairs - Compliant Scientific Scale Without Losing Trust или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Medical Affairs has to move fast without ever compromising credibility. Medical information teams face high-volume HCP questions. MSLs need rapid, accurate preparation for complex scientific exchanges. Evidence leaders must track a constant stream of new publications and congress data. Publications teams manage long, multi-step workflows under strict standards. That combination of speed plus scrutiny is exactly why generative AI agents are compelling in Medical Affairs, and why they must be designed differently than commercial agents. In this video, you’ll learn how compliant generative AI agents can scale scientific work across five core Medical Affairs capabilities: Medical Information responses with citation enforcement and safe refusal behavior MSL pre-call briefings and post-call insight structuring without embellishment KOL mapping built on verifiable professional activity and explainable evidence Publications planning and drafting support grounded in protocols, SAPs, and data Congress intelligence that summarizes at scale while clearly labeling uncertainty We also cover the operating model and guardrails that make Medical Affairs agents trustworthy: approved source boundaries, citations and claim-to-source mapping, version control, risk-based routing and escalation, audit logging, confidentiality controls, and metrics that track quality and cycle time, not just output volume. If you’re building an agent program this year, the fastest wins usually start with MI drafting plus MSL briefing generation using approved content libraries. Then expand into congress intelligence with source linking and uncertainty labeling, and only then mature KOL and publications workflows once governance is solid. Sources and further reading: FDA OPDP: https://www.fda.gov/drugs/office-pres... FDA Drug Guidance: https://www.fda.gov/drugs/guidances-d... ICMJE Recommendations: https://www.icmje.org/recommendations/ EQUATOR Network: https://www.equator-network.org/ CONSORT Statement: https://www.consort-statement.org/ ClinicalTrials.gov: https://clinicaltrials.gov/ EMA Scientific Guidelines: https://www.ema.europa.eu/en/human-re... Hashtags #MedicalAffairs #GenerativeAI #AIAgents #MedicalInformation #MSL #Publications #CongressIntel #Compliance #LifeSciences #ResponsibleAI Tags medical affairs, generative ai, ai agents, agentic ai, life sciences, pharma, medical information, MI responses, scientific exchange, MSL, medical science liaison, field medical, MSL enablement, KOL mapping, KOL intelligence, publications, scientific communications, publication planning, congress intelligence, congress coverage, evidence synthesis, literature review, citation required, claim mapping, audit trail, version control, compliant genai, responsible ai, privacy by design, data governance, on-label off-label, non-promotional, medical governance, safety language, pharmacovigilance, clinical guidelines, clinical trials, real world evidence, LLM governance, retrieval augmented generation, RAG, knowledge base, medical operations, digital medical affairs